GlassScriptPhysician profile
Ian Pieroni
NPI 1144097122
$3,985.32
in general payments reported to CMS, 2019-2025
29 companies · $3,319 in 2025
The $3,319 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $667 · 2025: $3,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,535 · Education: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,534.70 |
| Education | $450.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $578.58 | 2024-2025 | Airsupra, Fasenra, Breztri |
| Regeneron Healthcare Solutions, INC. | $381.22 | 2024-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $379.89 | 2024-2025 | Acthar |
| Genzyme Corporation | $370.56 | 2024-2025 | |
| Electromed, INC. | $220.85 | 2024-2025 | Smartvest |
| Pulmonx Corporation | $205.96 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Grifols USA, LLC | $201.58 | 2025 | Prolastin-C Liquid |
| Sanofi-Aventis U.S. LLC | $163.98 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $149.13 | 2025 | Lumryz |
| Harmony Biosciences LLC | $148.54 | 2025 | |
| Ethicon INC. | $119.15 | 2024 | Monarch Platform |
| Glaxosmithkline, LLC. | $116.47 | 2025 | Trelegy Ellipta, Nucala |
| Viatris Specialty LLC | $94.04 | 2025 | Yupelri |
| Lilly USA, LLC | $90.85 | 2025 | Zepbound |
| Baxter Healthcare | $79.45 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $79.20 | 2024-2025 | Keytruda |
| Mylan Specialty L.P. | $77.10 | 2024 | Yupelri |
| United Therapeutics Corporation | $72.67 | 2024-2025 | Tyvaso, Tyvaso |
| Ani Pharmaceuticals, INC. | $66.57 | 2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $62.09 | 2025 | Opsumit |
| Axsome Therapeutics, INC. | $56.00 | 2025 | Sunosi |
| Genentech USA, INC. | $53.38 | 2025 | Xolair |
| Jazz Pharmaceuticals INC. | $52.15 | 2025 | |
| Philips North America LLC | $45.42 | 2025 | Patient Interface Software, Incourage Airway Clearance Therapy |
| Inogen, INC. | $36.11 | 2024-2025 | |
| Verona Pharma, INC. | $32.88 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.42 | 2025 | Jascayd |
| Amgen INC. | $16.39 | 2025 | Tezspire |
| Inspire Medical Systems, INC. | $15.69 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Pieroni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.